Epygenix Therapeutics Successfully Completes EPX-100 Phase I, Placebo-Controlled, Double-Blind, 2-Period Study and Ready to Phase 2 Studies

Read Full Press Release Here:

https://www.prnewswire.com/news-releases/epygenix-therapeutics-successfully-completes-epx-100-phase-i-placebo-controlled-double-blind-2-period-study-and-ready-to-phase-2-studies-300993228.html